What should our patients with NAFLD eat? Expert faculty explore the evidence behind different diets in NAFLD/NASH.
Listen as expert hepatologist faculty explore the evidence behind different diets in NAFLD/NASH.
Listen as expert endocrinologist faculty explore the evidence behind different diets in NAFLD/NASH.
Explore the latest on NASH screening and the interplay between NAFLD, metabolic syndrome, CV risk, and diabetes risk.
Listen as expert hepatologist faculty explore NASH screening and interplay between NAFLD, metabolic syndrome, CV risk, diabetes risk.
Listen as expert endocrinologist faculty explore NASH screening and interplay among NAFLD, metabolic syndrome, CV risk, diabetes risk.
Weigh the latest perspectives on wet biomarkers, imaging, and combination tests.
Listen as expert hepatologist faculty weigh the latest perspectives on wet biomarkers, imaging, and combination tests.
Listen as expert endocrinologist faculty weigh the latest perspectives on wet biomarkers, imaging, and combination tests.
Learn the place of available approaches to managing NASH, including lifestyle and vitamin E, and compounds that target insulin resistance.
Listen as expert hepatologist faculty discuss the place of available approaches to managing NASH, including lifestyle and vitamin E, and compounds that target insulin resistance.
Listen as expert endocrinologist faculty discuss the place of available approaches to managing NASH, including lifestyle and vitamin E, and compounds that target insulin resistance.
Listen as expert endocrinologist faculty discuss agents in late-phase clinical trials and their potential use in treatment.
Listen as expert hepatologist faculty agents in late-phase clinical trials and their potential use in treatment.
Learn about the agents in late-phase clinical trials and their potential use in treatment.
Hear Brent A. Neuschwander-Tetri, MD, explore NASH screening and the interplay among NAFLD, metabolic syndrome, CV risk, and diabetes risk.
Hear Philip N. Newsome, PhD, FRCPE, discuss available approaches to managing NASH, including lifestyle, vitamin E, and compounds that target insulin resistance.
Hear Philip N. Newsome, PhD, FRCPE, discuss the agents in late-phase clinical trials and their potential use in the treatment of NASH and fibrosis.
Hear Stephen A. Harrison, MD, COL (Ret.), FAASLD, weigh the latest perspectives on wet biomarkers, imaging, and combination tests for NASH.
What should our patients with NAFLD eat? Listen as expert hepatologist Rotonya Carr, MD, explores the evidence behind different diets in NAFLD/NASH.
American Gastroenterological Association (AGA)
4930 Del Ray Avenue
Bethesda, MD 20814
Phone: (301) 654-2055
Fax: (301) 654-5920
Email: member@gastro.org
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.